DDInter917 DDInter1082
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. [PubChem]
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Indinavir {u} (Compound) resembles {v} (Compound) Alvimopan
Indinavir {u} (Compound) treats {v} (Disease) acquired immunodeficiency syndrome
Indinavir {u} (Compound) binds {v} (Gene) CYP2D6
Indinavir {u} (Compound) upregulates {v} (Gene) SSBP2
Indinavir {u} (Compound) downregulates {v} (Gene) MIF
Indinavir {u} (Compound) causes {v} (Side Effect) Body temperature increased
Indinavir {u} may cause a minor interaction that can limit clinical effects when taken with {v} Medroxyprogesterone acetate
Indinavir {u} may cause a minor interaction that can limit clinical effects when taken with {v} Fluconazole
Indinavir {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Lidocaine
Indinavir {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Aldesleukin
Indinavir (Compound) resembles Alvimopan (Compound)
Indinavir (Compound) treats acquired immunodeficiency syndrome (Disease)
Indinavir (Compound) binds CYP2D6 (Gene)
Indinavir (Compound) upregulates SSBP2 (Gene)
Indinavir (Compound) downregulates MIF (Gene)
Indinavir (Compound) causes Body temperature increased (Side Effect)
Indinavir may cause a minor interaction that can limit clinical effects when taken with Medroxyprogesterone acetate
Indinavir may cause a minor interaction that can limit clinical effects when taken with Fluconazole
Indinavir may cause a moderate interaction that could exacerbate diseases when taken with Lidocaine
Indinavir may cause a moderate interaction that could exacerbate diseases when taken with Aldesleukin